# Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

> **NCT01032902** · — · COMPLETED · sponsor: **Chembio Diagnostic Systems, Inc.** · enrollment: 2808 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DEVICE:** In Vitro Diagnostic Device

## Key facts

- **NCT ID:** NCT01032902
- **Lead sponsor:** Chembio Diagnostic Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 2808 (ACTUAL)
- **Last updated:** 2012-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01032902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01032902, "Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01032902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*